📰 Randomized Evaluation News
Randomized Evaluation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Randomized Evaluation. Real-time updates on events, politics, business and more.
April 9, 2024
The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.
April 7, 2024
REDUCE-AMI concluded beta-blockers show no significant benefit following myocardial infarction among patients with normal left ventricular ejection fraction
November 20, 2023
This Viewpoint discusses the use of privacy-preserving record linkage, a token-based record linkage system, as a promising avenue for building a data infrastruc
September 25, 2023
The designation of contact precautions as an "essential practice" for MRSA prevention.
September 7, 2023
A pharmacist shows a box of tocilizumab, which is used to treat rheumatoid arthritis, in the pharmacy of Cambrai Hospital in France on April 28, 2020.
July 18, 2023
Politics and lack of trust in public health threaten future crisis responses
June 8, 2023
The University of Chicago Education Lab today released a new study that found school-based group counseling programs can significantly reduce PTSD, anxiety, and depression among Black and Latina girls.
June 2, 2023
This open label clinical trial compares the effects of dexamethasone vs usual care on the number of days alive and free of mechanical ventilation at day 28 amon
May 20, 2023
Treatment of Aficamten was Well-Tolerated and Associated with Statistically Significant Improvements in KCCQ, Angina Frequency, NYHA Class, NTpro-BNP and...
May 20, 2023
Treatment of Aficamten was Well-Tolerated and Associated with Statistically Significant Improvements in KCCQ, Angina Frequency, NYHA Class, NTpro-BNP and High-Sensitivity Troponin I Phase 3 Clinical... | May 20, 2023